Brief: Active Biotech Announce Results In Arpeggio Phase II Trial With Laquinimod In Primary Progressive MS

Active Biotech AB publ

01/12/2017 12:00

Dec 1 (Reuters) - Active Biotech AB  ACTI.ST : 
    * ACTIVE BIOTECH ANNOUNCE RESULTS IN ARPEGGIO PHASE II TRIAL 
WITH 
LAQUINIMOD IN PRIMARY PROGRESSIVE MS 
 
Source text for Eikon:  ID:nGNXOJBNJa  
Further company coverage:  ACTI.ST  
 
 ((Bangalore.newsroom@thomsonreuters.com;))